Because melanoma breakthroughs are cancer breakthroughs. Every hour, someone in the United States dies from melanoma. It is the deadliest form of skin cancer, yet research into melanoma has transformed cancer care for millions worldwide.
In 2025, over 100,000 people will hear the words "you have melanoma". Melanoma cases are on the rise. For patients with advanced stages of melanoma, half will not respond to treatments. For those with rare forms like acral, mucosal and uveal melanoma or those who stop responding to treatment altogether, options are heartbreakingly limited. Behind these numbers are mothers, fathers, children and friends whose lives are on the line.
Breakthroughs in immunotherapy and targeted therapies - first proven in melanoma - are now saving lives in lung cancer, kidney cancer, head and neck cancers and beyond. The Melanoma Research Alliance's (MRA) mission to end death and suffering due to melanoma is equally relentless. We proudly stand behind 17 groundbreaking treatments over the past two decades, and are laser focused on helping patients that still need options to live.
MRA is the world's largest non-governmental, nonprofit funder of melanoma research, having invested in more than 400 projects across 19 countries. Our work has helped bring 17 new treatments to patients in just the past two decades - a pace few fields can match. All gifts are matched dollar-for-dollar to double your impact. MRA has earned Candid's Platinum Seal of Transparency and a top four-star rating from Charity Navigator, giving you confidence that your support drives real progress.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser
